Direct quantitative bioanalysis of drugs in dried blood spot samples using a thin-layer chromatography mass spectrometer interface.
about
Advantages and Challenges of Dried Blood Spot Analysis by Mass Spectrometry Across the Total Testing ProcessThe development and validation of a fast and robust dried blood spot based lipid profiling method to study infant metabolism.Approaches for the rapid identification of drug metabolites in early clinical studies.Microassay of drugs and modern measurement techniques.Peptide and protein drug analysis by MS: challenges and opportunities for the discovery environment.Direct analysis of dried blood spots coupled with mass spectrometry: concepts and biomedical applications.Emerging liquid chromatography-mass spectrometry technologies improving dried blood spot analysis.Biological sample preparation: attempts on productivity increasing in bioanalysis.Therapeutic drug monitoring by dried blood spot: progress to date and future directions.The use of mass spectrometry to analyze dried blood spots.Spot them in the spot: analysis of abused substances using dried blood spots.Quantitative mass spectrometry methods for pharmaceutical analysis.Automated high throughput analysis of antiretroviral drugs in dried blood spots.Stability of metabolites in dried blood spots stored at different temperatures over a 2-year period.DART-Orbitrap MS: a novel mass spectrometric approach for the identification of phenolic compounds in propolis.Evaluation of blood microsampling techniques and sampling sites for the analysis of drugs by HPLC-MS.A powerful couple in the future of clinical biochemistry: in situ analysis of dried blood spots by ambient mass spectrometry.A digital microfluidic method for dried blood spot analysis.Multiplexed extraction and quantitative analysis of pharmaceuticals from DBS samples using digital microfluidics.A method for the direct injection and analysis of small volume human blood spots and plasma extracts containing high concentrations of organic solvents using revered-phase 2D UPLC/MS.Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations.Automated high-capacity on-line extraction and bioanalysis of dried blood spot samples using liquid chromatography/high-resolution accurate mass spectrometry.Continuous-flow liquid microjunction surface sampling probe connected on-line with high-performance liquid chromatography/mass spectrometry for spatially resolved analysis of small molecules and proteins.Direct analysis of dried blood spots by in-line desorption combined with high-resolution chromatography and mass spectrometry for quantification of maple syrup urine disease biomarkers leucine and isoleucine.New bioanalytical technologies and concepts: worth the effort?Application of DBS for quantitative assessment of the peptide Exendin-4; comparison of plasma and DBS method by UHPLC-MS/MS.Rapid analysis of dried blood spot samples with sub-2-µm LC-MS/MS.Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/Orbitrap mass spectrometer.Utilization of DBS within drug discovery: development of a serial microsampling pharmacokinetic study in mice.Automated liquid microjunction surface sampling-HPLC-MS/MS analysis of drugs and metabolites in whole-body thin tissue sections.Semi-automated direct elution of dried blood spots for the quantitative determination of guanfacine in human blood.Use of conventional bioanalytical devices to automate DBS extractions in liquid-handling dispensing tips.Dried blood spot punches for confirmation of suspected γ-hydroxybutyric acid intoxications: validation of an optimized GC-MS procedure.Quantitation of Fentanyl Analogs in Dried Blood Spots by Flow-Through Desorption Coupled to Online Solid Phase Extraction Tandem Mass Spectrometry.Assessment of the within- and between-lot variability of Whatman™ FTA(®) DMPK and 903(®) DBS papers and their suitability for the quantitative bioanalysis of small molecules.Optimization of an automated IS addition system for use in high-throughput quantitative DBS analysis.DBS direct elution: optimizing performance in high-throughput quantitative LC-MS/MS analysis.Dried matrix spot direct analysis: evaluating the robustness of a direct elution technique for use in quantitative bioanalysis.Metabolite profiles from dried blood spots for metabonomic studies using UPLC combined with orthogonal acceleration ToF-MS: effects of different papers and sample storage stability.Ambient desorption ionization mass spectrometry (DART, DESI) and its bioanalytical applications
P2860
Q29109543-F12B63D9-AB25-4966-B646-16180E1A0093Q34091272-6337E615-E495-4792-A9C4-4859668688EAQ37830698-27389748-4C4F-4D68-89D1-71EF49907663Q37841718-9DF52547-6322-48D0-A7EC-B41CF335E089Q37854632-C401AE37-5F88-4E7F-9B53-404C660669EBQ37894587-13144C0C-4D1A-4943-BCEC-7727770EE291Q38201783-6BD492FD-9FF0-43A1-8C57-A0731840CE8FQ38235443-BE2E9D46-DBFB-4FBB-8438-9972A94BFB51Q38247481-17162FBA-5D0D-474A-AD46-7AE58BFA4D85Q38253959-07E36ADC-8FF3-4558-BAAB-370EC3B60AD2Q38266512-597D857F-A544-4DB6-904F-93D88ACF7C34Q38958771-A556B3F8-9B67-42FD-94FE-DED544AFD7D5Q38980411-C770420C-66F5-4438-B72F-8B47A0816611Q39397563-A29AC177-503C-4D08-BFC9-5ED0E407BEE0Q39649277-352AFCDF-1C8E-41B6-923D-6DB7CBE6BA55Q39791872-CD5990D8-658A-4875-B0F0-FEEB4F2B03C1Q39816327-BF57C7E3-D12C-4D6B-8081-9A2DAA9186F7Q39996250-4599DFF0-8F48-494A-8E45-EFE289E0A494Q40167311-B26C37AD-74C5-49AE-9FAC-00520AA9CF7BQ41474335-52410CC9-2C40-41BA-BD56-14403DE1E300Q42806889-752473CB-BD63-4E3A-8116-6FF9AA1E8390Q43508896-81DA794D-F681-4C10-8DBA-48CA8AF454ADQ44594852-D2F3095E-72CF-44DD-AA93-8A11701DFB0DQ44963401-ACE0BD48-3DAD-427E-8949-1C987F95CE05Q45283063-06F9E707-D648-462A-99D2-AC4482787F10Q45400105-D8A20987-21CE-4329-8E4F-6B48A65B8948Q45733811-4E4B7107-13D8-457E-9083-D11A8EE9B302Q45854049-1DCD4D0B-F89F-422A-A9BA-26A6AADFEE08Q45998866-B52DF8C4-53A7-4057-BD94-C2832E1B40AFQ46045398-D7BE82B4-FE13-464C-8FA2-EB30FE02CC8DQ47387427-9B70BF0B-C53A-4C78-9E9A-6D8349893ED1Q48221188-DD04B47B-7693-4815-9138-1CCFDEB90B9CQ49044992-BB09D4D7-8FD4-4603-B0D3-6227D025B0EBQ49584050-C320CA70-2378-4626-B9F7-C24BD781DF61Q50469847-71482B26-4DDA-413F-8F5B-71B3333F6607Q51647093-A13EC89F-7B69-4D93-A171-A4227439A6BEQ51788759-689F4E45-AC7F-4AF0-B310-B413C751B290Q53394043-493BA2C6-1021-4531-AC37-F7D3F941F59DQ53394045-C9F8DDFE-5E21-4175-A54E-5F104075B171Q56866376-CE907DB3-BE3F-41A4-8166-0E16FC7A6D6A
P2860
Direct quantitative bioanalysis of drugs in dried blood spot samples using a thin-layer chromatography mass spectrometer interface.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Direct quantitative bioanalysi ...... y mass spectrometer interface.
@en
Direct quantitative bioanalysi ...... y mass spectrometer interface.
@nl
type
label
Direct quantitative bioanalysi ...... y mass spectrometer interface.
@en
Direct quantitative bioanalysi ...... y mass spectrometer interface.
@nl
prefLabel
Direct quantitative bioanalysi ...... y mass spectrometer interface.
@en
Direct quantitative bioanalysi ...... y mass spectrometer interface.
@nl
P356
P1433
P1476
Direct quantitative bioanalysi ...... hy mass spectrometer interface
@en
P2093
Paul Abu-Rabie
P304
10275-10284
P356
10.1021/AC901985E
P407
P50
P577
2009-12-01T00:00:00Z